Skip to Navigation Skip to Search Skip to Content
Search All Centers

Lung Cancer

Lung cancer is the leading cause of cancer-related mortality in the United States and is comprised of two main histologic subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Fortunately, advanced drug therapies and genetic testing are making a big difference for many patients and their families.

Hear from highly-regarded lung cancer experts, nurse practitioners and patients from across the globe.

Upcoming Events

See all events
Oct 29 2020

Immunotherapy For Lung Cancer Brings Treatment Breakthroughs

Thursday, October 29, 2020
Time: 1:30 PM – 2:15 PM Pacific Time (US and Canada)

Immunotherapies have radically changed treatment for non-small cell lung cancer (NSCLC) patients. In fact, the PD-L1/PD-1 blockade is a bona fide breakthrough.  What does this fast-moving course of research and treatment mean for lung cancer patients of all persuasions? 

Topic Area: Lung Cancer
Type: Online
Time: 1:30 PM – 2:15 PM Pacific Time (US and Canada)

Latest News